Adicet Bio Inc (NASDAQ:ACET) price on Friday, June 13, fall -3.80% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.75.
A look at the stock’s price movement, the close in the last trading session was $0.78. Turning to its 52-week performance, $1.70 and $0.45 were the 52-week high and 52-week low respectively. Overall, ACET moved 16.34% over the past month.
Adicet Bio Inc’s market cap currently stands at around $62.06 million, with investors looking forward to this quarter’s earnings report slated for in July.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend ACET as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ACET’s current price about 0.95% and 14.28% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 52.74, while 7-day volatility ratio is 4.99% and 6.73% in the 30-day chart. Further, Adicet Bio Inc (ACET) has a beta value of 1.69, and an average true range (ATR) of 0.06. Analysts have given the company’s stock an average 52-week price target of $32.5, forecast between a low of $27 and high of $38. Looking at the price targets, the low is -3500.0% off current price level while to achieve the yearly target high, price needs to move -4966.67%. Nonetheless, investors will most likely welcome a -4233.33% jump to $32.5 which is the analysts’ median price.
If we refocus on Adicet Bio Inc (NASDAQ:ACET), historical trading data shows that trading volumes averaged 524.50K over the past 3 months. The company’s latest data on shares outstanding shows there are 82.71 million shares.
The 20.96% of Adicet Bio Inc’s shares are in the hands of company insiders while institutional holders own 49.04% of the company’s shares. Current price change has pushed the stock -22.01% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ACET stock continues to rise going into the next quarter.
